HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Approval overview HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 089200 (ANDA).
Marketing status: Discontinued Active ingredient HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength CAPSULE;ORAL - 25MG;25MG Sponsor SUPERPHARM Submission history Latest submission status date: 1989-02-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 089200 (ANDA). Marketing status: Discontinued Active ingredient HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength CAPSULE;ORAL - 25MG;25MG Sponsor SUPERPHARM Submission history Latest submission status date: 1989-02-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.